| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_170c8ebd815eccf6cd88533c412db263 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-75 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y203-01028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-122 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
1999-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e774e21d165a5e3edc2e440db7311bde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0448b1964e8ffa0d5b87c390acaf143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ccae01895484b2858bf2185d2836b07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac7f3b843a6551b81453b490f1913004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e3362b005fa4091154b21a03ec14a11 |
| publicationDate |
2001-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6303340-B1 |
| titleOfInvention |
Method for producing a peptide with a pI above 8 or below 5 |
| abstract |
A method is described for producing a peptide having a pI above 8 or below 5 wherein the peptide is expressed as a fusion protein in which it is linked to a fusion partner through an acid cleavage site. The peptide is released from the fusion partner by acid cleavage in the absence of chaotrope. The fusion partner and its acid cleavage products, if any, have a net charge sufficiently different from that of the desired peptide to allow isolation of the peptide by ion-exchange chromatography. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8748399-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015099860-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009035815-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006041945-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006041945-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006148699-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6506566-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609621-B2 |
| priorityDate |
1998-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |